EUVIMEDEUVIMED entdecken
Open Access

Bridged bicyclic compounds: Comprehending a novel compound class as potential anti‐seizure agents

Samantha E Stilley, Akshay S Naraine iD, Krishna P Yadavalli, Samantha L Maki, Elyse M Jutte, Jared M Kahn, Alexis A Surtel, Salvatore D Lepore, Ken Dawson-Scully

Epilepsia · 2023-11 · 64 (11) · 2958-2967

DOI: 10.1111/epi.17769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 19.09.2023. Verfasst von Samantha E Stilley und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, Florida, USA. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Anticonvulsants. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In the present study, we describe a novel class of small‐molecule synthetic compounds that ameliorate seizure‐like behavior, using an electroshock assay to examine seizure duration in Caenorhabditis elegans . We also examine the hypothesis that these compounds, which we have called resveramorphs (RVMs), act by an irreversible binding mechanism.

Methods

Our electroshock assay examines seizure duration in C. elegans and can be used as a drug‐screening platform for the identification of novel anti‐seizure agents. The use of C. elegans allows for a rapid and efficient method of drug screening that may take years in other higher‐order model organisms. A novel wash method, paired with our electroshock assay, allows us to discern differences in biological activity when the C. elegans are incubated in different drug solutions, to establish whether these compounds can be “washed” off.

Results

One of the RVMs (RVM‐3), reported here for the first time, was found to be potent at picomolar concentrations. Insights also provided information on the potential mechanisms of action of this compound. Covalent binding is thought to provide a strong irreversible bond because of a change in structure between two of the novel RVMs described in this work. This was also discerned through the novel wash method paired with our electroshock assay. Significance RVM‐3 was evaluated using our assay and found to possess anti‐seizure activity at picomolar concentrations. These insights also provide information on the potential mechanisms of action of these compounds, which may include covalent binding. This was also discerned through a novel wash method paired with our electroshock assay.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caenorhabditis elegansAnticonvulsantsAnimalsElectroshockDisease Models, AnimalSeizures

Stichwörter der Autor:innen

antiepileptic drugcovalent inhibitiondrug discoveryelectroshockneuropharmacology

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Department of Biology, Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, Florida, USA.
  • IMPRS for Synapses and Circuits, Max Planck Florida Institute for Neuroscience, Jupiter, Florida, USA.
  • Department of Chemistry and Biochemistry, Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, Florida, USA.
  • Department of Psychology and Neuroscience, College of Psychology, Nova Southeastern University, Davie, Florida, USA.

ORCID-Profile: Akshay S Naraine

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Stilley, S. E., Naraine, A. S., Yadavalli, K. P., Maki, S. L., Jutte, E. M., Kahn, J. M., Surtel, A. A., Lepore, S. D., & Dawson-Scully, K. (2023). Bridged bicyclic compounds: Comprehending a novel compound class as potential anti‐seizure agents. Epilepsia, 64(11), 2958-2967. https://doi.org/10.1111/epi.17769

Vancouver

Stilley SE, Naraine AS, Yadavalli KP, Maki SL, Jutte EM, Kahn JM, et al. Bridged bicyclic compounds: Comprehending a novel compound class as potential anti‐seizure agents. Epilepsia. 2023;64(11):2958-2967. doi:10.1111/epi.17769

BibTeX
@article{Stilley2023,
  author = {Stilley, Samantha E and Naraine, Akshay S and Yadavalli, Krishna P and Maki, Samantha L and Jutte, Elyse M and Kahn, Jared M and Surtel, Alexis A and Lepore, Salvatore D and Dawson-Scully, Ken},
  title = {Bridged bicyclic compounds: Comprehending a novel compound class as potential anti‐seizure agents},
  journal = {Epilepsia},
  year = {2023},
  volume = {64},
  number = {11},
  pages = {2958--2967},
  doi = {10.1111/epi.17769}
}
Kostenlos starten →